Skip to main content

Wako Distributing Cellectis Products in Japan

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genomic engineering firm Cellectis said on Wednesday it has appointed Wako Pure Chemical Industries as its exclusive distributor in Japan.

Wako will handle sales of Cellectis' products including its Talen Access service, launched in February. In a statement, Luc Selig, vice president of sales and marketing for Cellectis, said that the company is targeting global distribution of Talen, which is a tool for specifically modifying genes in any type of cell.

Calling Japan a "major player in life science research," he said that "Wako will allow us to enter this important market effectively."

Financial and other terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.